ANI Pharmaceuticals IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 81.78 USD | 99,5 USD | 62,605 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 110 USD | 3 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 22.734.618 | 18,1 | 9,99 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name ANI Pharmaceuticals Inc
Mitarbeiter 970
Handelsplatz NASDAQ
Ticker Symbol ANIP
IPO Datum 2000-05-05
Adresse 210 Main Street West, Baudette, MN, United States, 56623
Webseite https://www.anipharmaceuticals.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Nikhil Lalwani | President, CEO & Director |
| 2 | Mr. Stephen P. Carey | Senior VP of Finance & CFO |
| 3 | Ms. Meredith W. Cook J.D. | Senior VP, General Counsel & Corporate Secretary |
| 4 | Mr. Christopher K. Mutz | Senior VP & Head of Rare Disease |
| 5 | Mr. Ori Gutwerg | Senior Vice President of Generics |
| 6 | Mr. Muthusamy Shanmugam MS R.Ph. | Head of R&D, COO of New Jersey Operations & Director |
| 7 | Ms. Elizabeth Powell J.D. | Chief Compliance Officer & Head of Legal of Rare Disease |
| 8 | Mr. Chad Gassert | Senior Vice President of Corporate Development & Strategy |
| 9 | Ms. Krista L. Davis | Senior VP & Chief Human Resources Officer |
| 10 | Dr. Mary Pao M.D., Ph.D. | Chief Medical Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | TANG CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 7 | Goldentree Asset Management LP | 0,00% | 0,00 Mio. USD |
| 8 | Deep Track Capital, LP | 0,00% | 0,00 Mio. USD |
| 9 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 10 | Arrowstreet Capital Limited Partnership | 0,00% | 0,00 Mio. USD |
| 11 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 12 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 13 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Global Alpha Capital Management Ltd. | 0,00% | 0,00 Mio. USD |
| 17 | Ranger Investment Management LP | 0,00% | 0,00 Mio. USD |
| 18 | William Blair Investment Management, LLC | 0,00% | 0,00 Mio. USD |
| 19 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 20 | Deutsche Bank AG | 0,00% | 0,00 Mio. USD |